Imperial College London
Alternate

MrJosephShalhoub

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

j.shalhoub Website

 
 
//

Location

 

Charing Cross HospitalCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Marshall:2022:10.1186/s12890-022-02074-z,
author = {Marshall, DC and Al, Omari O and Goodall, R and Shalhoub, J and Adcock, IM and Chung, KF and Salciccioli, JD and Marshall, D and Al, Omari O and Goodall, R and Shalhoub, J and Adcock, I and Chung, K and Salciccioli, J},
doi = {10.1186/s12890-022-02074-z},
journal = {BMC Pulmonary Medicine},
pages = {1--11},
title = {Trends in prevalence, mortality, and disability-adjusted life-years relating to chronic obstructive pulmonary disease in Europe: an observational study of the global burden of disease database, 2001-2019},
url = {http://dx.doi.org/10.1186/s12890-022-02074-z},
volume = {22},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - IntroductionChronic Obstructive Pulmonary Disease (COPD) is associated with significant mortality and well-defined aetiological factors. Previous reports indicate that mortality from COPD is falling worldwide. This study aims to assess the burden of COPD using prevalence, mortality, and disability-adjusted life years (DALYs) between 2001 and 2019 in 28 European countries (the European Union and the United Kingdom).MethodsWe extracted COPD data from the Global Burden of Disease database based on the International Classification of Diseases versions 10 (J41, 42, 43, 44 and 47). Age-standardised prevalence rates (ASPRs), age-standardised mortality rates (ASMRs), and DALYs were analysed for European countries by sex for each year (2001–2019) and reported per 100,000 population. We used Joinpoint regression analysis to quantify changing trends in the burden of COPD.ResultsIn 2019, the median ASPR across Europe was 3230/100,000 for males and 2202/100,000 for females. Between 2001 and 2019, the median percentage change in ASPR was − 9.7% for males and 4.3% for females. 23/28 countries demonstrated a decrease in ASPRs in males, and 11/28 demonstrated a decrease in females. The median percentage change in ASMR between 2001 and 2019 was − 27.5% for males and − 10.4% for females. 25/28 and 19/28 countries demonstrated a decrease in ASMR in males and females, respectively.ConclusionIn the EU between 2001 and 2019 COPD prevalence has overall increased in females but continues to decrease in males and in some countries, female prevalence now exceeds that of males. COPD mortality in the EU has decreased overall between 2001 and 2019; however, this decrease is not universal, particularly in females, and therefore remains a substantial source of amenable mortality.
AU  - Marshall,DC
AU  - Al,Omari O
AU  - Goodall,R
AU  - Shalhoub,J
AU  - Adcock,IM
AU  - Chung,KF
AU  - Salciccioli,JD
AU  - Marshall,D
AU  - Al,Omari O
AU  - Goodall,R
AU  - Shalhoub,J
AU  - Adcock,I
AU  - Chung,K
AU  - Salciccioli,J
DO  - 10.1186/s12890-022-02074-z
EP  - 11
PY  - 2022///
SN  - 1471-2466
SP  - 1
TI  - Trends in prevalence, mortality, and disability-adjusted life-years relating to chronic obstructive pulmonary disease in Europe: an observational study of the global burden of disease database, 2001-2019
T2  - BMC Pulmonary Medicine
UR  - http://dx.doi.org/10.1186/s12890-022-02074-z
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000832681300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-022-02074-z
UR  - http://hdl.handle.net/10044/1/98357
VL  - 22
ER  -
Download